Meningitis
📧 Sign up to get email alerts when something new happens for Meningitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-02-19Clinical Trial Update: Infections of the Central Nervous System
The clinical trial investigating infections of the central nervous system in adults with suspected meningitis and/or encephalitis has been w…
-
EMA withdrawal · 2025-02-05EMA Withdrawn: Penbraya (Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group W polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group B fHBP protein subfamily A;Neisseria meningitidis group B fHBP protein subfamily B) — Pfizer Europe MA EEIG
EMA has withdrawn the marketing authorization for Penbraya, a meningococcal vaccine developed by Pfizer Europe MA EEIG. The withdrawal took …
-
CLINICAL_TRIALS withdrawal · 2017-04-05Clinical Trial Update: Host-pathogen Interactions in Meningococcal Disease: Finding the Key That Fits the Lock
A Public Health England-sponsored clinical trial on host-pathogen interactions in meningococcal disease has been withdrawn.